{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:03:01Z","timestamp":1779379381000,"version":"3.53.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T00:00:00Z","timestamp":1201651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2,16]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Reduced B cell numbers and a mutation in Btk are considered sufficient to make the diagnosis of X-linked agammaglobulinaemia. In the process of conducting family studies, we identified a 58-year-old healthy man with an amino acid substitution, Y418H, in the adenosine-5\u2032-triphosphate binding site of Btk. Immunofluorescence studies showed that this man had 0\u00b785% CD19+ B cells (normal 4\u201318%) in the peripheral circulation and his monocytes were positive for Btk. He had borderline low serum immunoglobulins but normal titres to tetanus toxoid and multiple pneumococcal serotypes. To determine the functional consequences of the amino acid substitution, a Btk\u2013 chicken B cell line, DT40, was transfected with expression vectors producing wild-type Btk or Y418H Btk. The transfected cells were stimulated with anti-IgM and calcium flux and inositol triphosphate (IP3) production were measured. Cells bearing the mutant protein demonstrated consistently a 15\u201320% decrease in both calcium flux and IP3 production. These findings indicate that even a modest decrease in Btk function can impair B cell proliferation or survival. However, a mutation in Btk and reduced numbers of B cells are not always associated with clinical disease.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2008.03593.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T20:24:09Z","timestamp":1280175849000},"page":"39-44","source":"Crossref","is-referenced-by-count":23,"title":["A minimally hypomorphic mutation in Btk resulting in reduced B cell numbers but no clinical disease"],"prefix":"10.1093","volume":"152","author":[{"given":"M E","family":"Conley","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Tennessee College of Medicine"},{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D M","family":"Farmer","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K","family":"Dobbs","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Howard","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Aiba","sequence":"additional","affiliation":[{"name":"Laboratory for Lymphocyte Differentiation, RIKEN Research Center for Allergy and Immunology, Suehirocho, Tsurumi-ku, Yokohama, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S A","family":"Shurtleff","sequence":"additional","affiliation":[{"name":"Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kurosaki","sequence":"additional","affiliation":[{"name":"Laboratory for Lymphocyte Differentiation, RIKEN Research Center for Allergy and Immunology, Suehirocho, Tsurumi-ku, Yokohama, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,1,30]]},"reference":[{"key":"2022010405174511800_b1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1067\/mpd.2002.127711","article-title":"Clinical findings leading to the diagnosis of X-linked agammaglobulinemia","volume":"141","author":"Conley","year":"2002","journal-title":"J Pediatr"},{"key":"2022010405174511800_b2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005792-198505000-00001","article-title":"X-linked agammaglobulinemia: an analysis of 96 patients","volume":"64","author":"Lederman","year":"1985","journal-title":"Medicine"},{"key":"2022010405174511800_b3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/clim.2002.5241","article-title":"Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study","volume":"104","author":"Plebani","year":"2002","journal-title":"Clin Immunol"},{"key":"2022010405174511800_b4","first-page":"279","volume-title":"Primary immunodeficiency diseases: a molecular and genetic approach","author":"Smith","year":"2007"},{"key":"2022010405174511800_b5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinemia is a member of the src family of protein\u2013tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature"},{"key":"2022010405174511800_b6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","article-title":"Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia","volume":"72","author":"Tsukada","year":"1993","journal-title":"Cell"},{"key":"2022010405174511800_b7","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199405263302104","article-title":"A point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammagobulinemia","volume":"330","author":"Saffran","year":"1994","journal-title":"N Engl J Med"},{"key":"2022010405174511800_b8","first-page":"477","article-title":"Discordant phenotype in siblings with X-linked agammaglobulinemia","volume":"58","author":"Bykowsky","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2022010405174511800_b9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF03401645","article-title":"A novel mutation (Cys145-stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammglobulinemia in a 51-year-old male","volume":"2","author":"Kornfeld","year":"1996","journal-title":"Mol Med"},{"key":"2022010405174511800_b10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mpd.2001.115970","article-title":"A mutation in Bruton's tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency","volume":"139","author":"Wood","year":"2001","journal-title":"J Pediatr"},{"key":"2022010405174511800_b11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/clim.2001.5024","article-title":"A case of X-linked agammaglobulinemia diagnosed in adulthood","volume":"99","author":"Stewart","year":"2001","journal-title":"Clin Immunol"},{"key":"2022010405174511800_b12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.clim.2005.10.007","article-title":"Genotype\/phenotype correlations in X-linked agammaglobulinemia","volume":"118","author":"Broides","year":"2006","journal-title":"Clin Immunol"},{"key":"2022010405174511800_b13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaci.2005.04.043","article-title":"A genotype\u2013phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia","volume":"116","author":"Lopez-Granados","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"2022010405174511800_b14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4049\/jimmunol.152.2.557","article-title":"Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells","volume":"152","author":"Smith","year":"1994","journal-title":"J Immunol"},{"key":"2022010405174511800_b15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2141.2001.02905.x","article-title":"Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females","volume":"114","author":"Futatani","year":"2001","journal-title":"Br J Haematol"},{"key":"2022010405174511800_b16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.molimm.2007.07.005","article-title":"Identification of novel non-pathogenic mutation in SH3 domain of Btk in an XLA patient","volume":"45","author":"Perez de Diego","year":"2008","journal-title":"Mol Immunol"},{"key":"2022010405174511800_b17","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/humu.20410","article-title":"BTKbase: the mutation database for X-linked agammaglobulinemia","volume":"27","author":"Valiaho","year":"2006","journal-title":"Hum Mutat"},{"key":"2022010405174511800_b18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.0105-2896.2005.00233.x","article-title":"Genetic analysis of patients with defects in early B cell development","volume":"203","author":"Conley","year":"2005","journal-title":"Immunol Rev"},{"key":"2022010405174511800_b19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/clim.1998.4629","article-title":"Unusual mutations in Btk: an insertion, a duplication, an inversion and four large deletions","volume":"90","author":"Rohrer","year":"1999","journal-title":"Clin Immunol"},{"key":"2022010405174511800_b20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/humu.9321","article-title":"Two independent retrotransposon insertions at the same site within the coding region of BTK","volume":"25","author":"Conley","year":"2005","journal-title":"Hum Mutat"},{"key":"2022010405174511800_b21","first-page":"595","article-title":"Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection","volume":"91","author":"Futatani","year":"1998","journal-title":"Blood"},{"key":"2022010405174511800_b22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies","volume":"93","author":"Conley","year":"1999","journal-title":"Clin Immunol"},{"key":"2022010405174511800_b23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1086\/301828","article-title":"Mutations in Btk in patients with presumed X-linked agammaglobulinemia","volume":"62","author":"Conley","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2022010405174511800_b24","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.4049\/jimmunol.179.4.2055","article-title":"A hypomorphic mutation in Igbeta (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development","volume":"179","author":"Dobbs","year":"2007","journal-title":"J Immunol"},{"key":"2022010405174511800_b25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1074-7613(00)80012-6","article-title":"BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells","volume":"10","author":"Ishiai","year":"1999","journal-title":"Immunity"},{"key":"2022010405174511800_b26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF03401694","article-title":"Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia","volume":"3","author":"Saha","year":"1997","journal-title":"Mol Med"},{"key":"2022010405174511800_b27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1084\/jem.184.1.31","article-title":"A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2","volume":"184","author":"Takata","year":"1996","journal-title":"J Exp Med"},{"key":"2022010405174511800_b28","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1073\/pnas.96.11.6341","article-title":"Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein","volume":"96","author":"Yamadori","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010405174511800_b29","doi-asserted-by":"crossref","first-page":"13152","DOI":"10.1073\/pnas.94.24.13152","article-title":"Btk dosage determines sensitivity to B cell antigen receptor cross- linking","volume":"94","author":"Satterthwaite","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010405174511800_b30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1034\/j.1600-065X.2000.17809.x","article-title":"Defects in early B-cell development: comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse","volume":"178","author":"Conley","year":"2000","journal-title":"Immunol Rev"},{"key":"2022010405174511800_b31","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.4049\/jimmunol.162.11.6526","article-title":"Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region","volume":"162","author":"Maas","year":"1999","journal-title":"J Immunol"},{"key":"2022010405174511800_b32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00008480-199912000-00010","article-title":"Recent progress in the diagnosis and treatment of patients with defects in early B-cell development","volume":"11","author":"Minegishi","year":"1999","journal-title":"Curr Opin Pediatr"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03593.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03593.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/152\/1\/39\/42045111\/j.1365-2249.2008.03593.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/152\/1\/39\/42045111\/j.1365-2249.2008.03593.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T09:57:49Z","timestamp":1685699869000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/152\/1\/39\/6457554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,1,30]]},"published-print":{"date-parts":[[2008,2,16]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03593.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,4]]},"published":{"date-parts":[[2008,1,30]]}}}